Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

Share Price is delayed by 15 minutes
Get Live Data
15.95    0.00 (0.00%)
Bid:
15.00
Ask:
16.90
Spread: 1.90 (12.667%)
Market Cap: £12.88m
LMS Live PriceLast checked at - London Stock Exchange

Intraday Lms Capital Share Chart

NAV and Portfolio Update

2 Feb 2021 07:00

RNS Number : 6344N
LMS Capital PLC
02 February 2021
 

 

 

 

 

2 February 2021

 

LMS CAPITAL PLC

NAV Estimate as at 31 December 2020 and Dacian Update

 

LMS Capital plc (the "Company") the listed Investment Company provides the following Company update and estimate of net asset value ("NAV") as at 31 December 2020.

 

Net Asset Value Estimate

 

The Company has commenced the year end valuation review process which is based on the latest performance updates from portfolio companies and third-party fund manager valuations. The Board currently estimates that the year-end NAV will be in the region of £47.9 million (59.4p per share) compared to £46.5 million (57.5p per share) at 30 June 2020. This estimate reflects information currently available to the Board on the performance and prospects of individual investments in the Company's portfolio and is subject to further evaluation as well as completion of the annual audit.

 

The valuation methodology and policy adopted is consistent with prior years and is in line with IPEV guidelines.

 

The £1.4 million increase in NAV compared to the half year comprises the following principal elements:

 

· Excluding the effect of foreign exchange rate changes, the portfolio showed a net unrealised gain of £4.4 million in the second half of 2020:

o An increase of £1.6 million in the value of ICU Eyewear, principally from activity associated with its personal protective equipment line and including a cash distribution of £1.1 million expected to be received by the Company during the first quarter;

o An increase of £1.1 million in the value of Medhost reflecting a corresponding increase in value by Primus, the lead investment manager, in its latest available fund report;

o An increase of £0.8 million in the Opus Capital Ventures Partners fund;

o An increase of £0.4 million in Weber Capital Partners, a US listed company fund; and

o Other portfolio net gains were £0.5 million.

 

· Unrealised foreign exchange losses of £1.2 million on portfolio assets arising from the weakening of the US Dollar compared to the sterling in the period 30 June 2020 to 31 December 2020; and

 

· Other movements were a net reduction of £1.8 million and include the following:

o Running costs were £1.0 million in the second half of 2020. Full year running costs were £1.8 million;

o Investment support costs (transaction diligence costs and support costs for real estate and co-investment activities) were £0.1 million in the second half of 2020, bringing full year costs to £0.2 million;

o Unrealised foreign exchange losses of £0.7 million on non-portfolio assets, principally US Dollar bank accounts and the cash deposited for the investment in Dacian, due to the weakening of the US dollar against the sterling;

o £0.2 million for the dividend paid in September 2020; and

o Partially offset by £0.2 million in other net credits in the second half of 2020.

 

Further information on the performance of the portfolio, underlying investment valuations and changes during the year will be included in the Company's audited results for the year ended 31 December 2020, which it expects to announce in March 2021.

 

Group cash balances at 31 December 2020 were £20.6 million (30 June 2020: £29.0 million). The change in the second half of 2020 is principally attributable to the £7.0 million deposited for the Dacian investment and an additional £0.8 million investment in Weber Capital Partners.

 

Dacian Update

 

On 7 January 2021, the Company provided an update on its planned investment in Dacian, the Romanian oil and gas production company acquiring 40 onshore oil and gas field from OMV Petrom. The transaction remains in the final stages of the approval process. The Dacian team believes that the approval process will conclude satisfactorily, and the transaction will complete within a reasonable period of time.

 

Outlook

 

The Company continues to maintain significant cash balances, £20.6 million at 31 December 2020, and remains cautious about the way its liquid resources are deployed. Notwithstanding the impact and uncertainties around the Coronavirus pandemic, the Company made progress during 2020, particularly with its energy team and its real estate teams, in building a pipeline of opportunities. Further updates on these investment opportunities will be included in the Company's final results announcement in March 2021.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please contact:

 

LMS Capital PLC

Nick Friedlos, Managing Director

0207 935 3555

 

Shore Capital

Robert Finlay

0207 405 485

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVEAAAFEFPFEAA
Date   Source Headline
13th May 20263:32 pmRNSResults of 2026 Annual General Meeting
24th Apr 20263:37 pmRNSTR‑1: Notification of Major Holdings
24th Apr 20267:00 amRNSFirst Quarter 2026 Update
17th Apr 20261:09 pmRNSNotice of Annual General Meeting
19th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
17th Feb 202612:37 pmRNSTR‑1: Notification of Major Holdings
16th Feb 20267:00 amRNSCompany Update and Unaudited Net Asset Value
13th Jan 20267:00 amRNSSecond Return of Capital
4th Nov 20257:00 amRNS3rd Quarter Trading Update
8th Oct 20259:30 amRNSChange of Auditor
11th Aug 20257:01 amRNSHalf-year Report
11th Aug 20257:00 amRNSInvestment in Dacian
15th Jul 20253:21 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSStatement re B Share issue
15th May 202510:23 amRNSResult of AGM & GM
14th May 20253:01 pmRNSResult of AGM & GM
14th May 20257:00 amRNSAGM Statement
24th Apr 202510:43 amRNSNotice of GM Broadcast
24th Apr 202510:36 amRNSNotice of GM
22nd Apr 20257:00 amRNS1st Quarter Results
8th Apr 20251:47 pmRNSNotice of AGM Broadcast
8th Apr 20251:34 pmRNSNotice of AGM
28th Mar 20257:00 amRNSFinal Results
17th Mar 20259:07 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSStatement re proposed managed realisation
25th Feb 20251:27 pmRNSHolding(s) in Company
19th Feb 20258:44 amRNSHolding(s) in Company
13th Feb 20257:00 amRNSNet Asset Value(s)
20th Dec 20249:22 amRNSDirector/PDMR Shareholding
13th Nov 20244:32 pmRNSCompany Secretary Change
18th Oct 20247:00 amRNSThird Quarter 2024 Update
5th Sep 20243:49 pmRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSSenior Independent Director Appointment
31st Jul 20247:00 amRNSHalf-year Report
15th Jul 20247:00 amRNSUpdate on Investment
16th May 20244:54 pmRNSResult of AGM and Dividend Declaration
15th May 20247:00 amRNSDirectorate Change
8th May 20249:19 amRNS1st Quarter Results
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.